Hindustan Unilever filed a Writ Petition in the Bombay High Court to challenge a demand of INR 962.75 Crores from Income Tax Authorities related to non-deduction of TDS during a payment to acquire India HFD IPR from GlaxoSmithKline. The petition contests the legality of the Assessment Order dated 23rd August 2024.